Cargando…
Activin-β(C) modulates cachexia by repressing the ubiquitin-proteasome and autophagic degradation pathways
BACKGROUND: Cancer-associated cachexia and muscle wasting are considered key determinants of cancer-related death and reduction in the quality of life of cancer patients. A crucial link has been established between activin signaling and skeletal muscle atrophy-hypertrophy. We previously showed that...
Autores principales: | Marino, Francesco Elia, Risbridger, Gail, Gold, Elspeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670746/ https://www.ncbi.nlm.nih.gov/pubmed/26673867 http://dx.doi.org/10.1002/jcsm.12031 |
Ejemplares similares
-
Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab
por: Wang, Dawei, et al.
Publicado: (2019) -
Modulation of apoptosis sensitivity through the interplay with autophagic and proteasomal degradation pathways
por: Delgado, M E, et al.
Publicado: (2014) -
Pathway choice between proteasomal and autophagic degradation
por: Lu, Kefeng, et al.
Publicado: (2017) -
Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia
por: Khal, J, et al.
Publicado: (2005) -
MG132-mediated inhibition of the ubiquitin–proteasome pathway ameliorates cancer cachexia
por: Zhang, Liuping, et al.
Publicado: (2013)